litlas
ログインアカウント作成

Christopher J. H. Porter

1991–2025 年に発表

110
論文数
20,540
被引用数
80
h 指数
108
i10 指数

被引用数

Christopher J. H. Porter の年別被引用数1967 年: 被引用 1 件1992 年: 被引用 2 件1993 年: 被引用 9 件1994 年: 被引用 3 件1995 年: 被引用 9 件1996 年: 被引用 3 件1997 年: 被引用 9 件1998 年: 被引用 4 件1999 年: 被引用 5 件2000 年: 被引用 30 件2001 年: 被引用 47 件2002 年: 被引用 30 件2003 年: 被引用 49 件2004 年: 被引用 68 件2005 年: 被引用 56 件2006 年: 被引用 63 件2007 年: 被引用 210 件2008 年: 被引用 113 件2009 年: 被引用 160 件2010 年: 被引用 190 件2011 年: 被引用 201 件2012 年: 被引用 255 件2013 年: 被引用 319 件2014 年: 被引用 275 件2015 年: 被引用 231 件2016 年: 被引用 208 件2017 年: 被引用 176 件2018 年: 被引用 191 件2019 年: 被引用 817 件2020 年: 被引用 927 件2021 年: 被引用 842 件2022 年: 被引用 588 件2023 年: 被引用 493 件2024 年: 被引用 657 件2025 年: 被引用 259 件2026 年: 被引用 13 件1968〜1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,291 件、この内訳の 18.4%中国: 引用元論文 756 件、この内訳の 10.8%インド: 引用元論文 516 件、この内訳の 7.4%オーストラリア: 引用元論文 439 件、この内訳の 6.3%イギリス: 引用元論文 395 件、この内訳の 5.6%ドイツ: 引用元論文 272 件、この内訳の 3.9%フランス: 引用元論文 191 件、この内訳の 2.7%スイス: 引用元論文 177 件、この内訳の 2.5%デンマーク: 引用元論文 170 件、この内訳の 2.4%カナダ: 引用元論文 162 件、この内訳の 2.3%イタリア: 引用元論文 160 件、この内訳の 2.3%スペイン: 引用元論文 151 件、この内訳の 2.2%
0%18.4%その他 33.2%

機関

分野

  • Pharmacology, Toxicology and Pharmaceutics29.6%
  • Medicine20.9%
  • Biochemistry, Genetics and Molecular Biology16.1%
  • Materials Science12.9%
  • Immunology and Microbiology4.6%
  • Agricultural and Biological Sciences4.4%
  • その他11.5%

トピック

  • Drug Solubulity and Delivery Systems9.6%
  • Advanced Drug Delivery Systems7.5%
  • Nanoparticle-Based Drug Delivery4.7%
  • RNA Interference and Gene Delivery3.8%
  • Advancements in Transdermal Drug Delivery3.7%
  • Crystallization and Solubility Studies2.6%
  • その他68.1%

共著者

全論文

検索で開く
  1. Strategies to Address Low Drug Solubility in Discovery and Development

    著者: Hywel D. Williams, Natalie L. Trevaskis, Susan A. Charman, Ravi Shanker, William N. Charman, Colin W. Pouton, Christopher J. H. Porter - Pharmacological Reviews 2013 被引用: 1,544

  2. From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity

    著者: Natalie L. Trevaskis, Lisa M. Kaminskas, Christopher J. H. Porter - Nature Reviews Drug Discovery 2015 被引用: 639

  3. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs

    著者: Christopher J. H. Porter, Natalie L. Trevaskis, William N. Charman - Nature Reviews Drug Discovery 2007 被引用: 1,774

  4. Minimum information reporting in bio–nano experimental literature

    著者: Matthew Faria, Mattias Björnmalm, Kristofer J. Thurecht, Stephen J. Kent, Robert G. Parton, Maria Kavallaris, Angus P. R. Johnston, J. Justin Gooding, Simon R. Corrie, Ben J. Boyd, Pall Thordarson, Andrew K. Whittaker, Molly M. Stevens, Clive A. Prestidge, Christopher J. H. Porter, Wolfgang J. Parak, Thomas P. Davis, Edmund J. Crampin, Frank Caruso - Nature Nanotechnology 2018 被引用: 639

  5. The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group

    著者: Mirko Koziolek, Stefano Alcaro, Patrick Augustijns, Abdul W. Basit, Michael Grimm, Bart Hens, Caroline L. Hoad, Philipp Jedamzik, Christine M. Madla, Marc Maliepaard, Luca Marciani, Annalisa Maruca, Neil Parrott, Petr Pávek, Christopher J. H. Porter, Christos Reppas, Diana A. van Riet‐Nales, Jari Rubbens, Marina Statelova, Natalie L. Trevaskis, Kateřina Valentová, Maria Vertzoni, Dubravka Vitali Čepo, Maura Corsetti - European Journal of Pharmaceutical Sciences 2019 被引用: 367

  6. Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies

    著者: Colin W. Pouton, Christopher J. H. Porter - Advanced Drug Delivery Reviews 2007 被引用: 872

  7. Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief

    著者: Dane D. Jensen, TinaMarie Lieu, Michelle L. Halls, Nicholas A. Veldhuis, Wendy L. Imlach, Quynh N. Mai, Daniel P. Poole, Tim Quach, Luigi Aurelio, Joshua Conner, Carmen Klein Herenbrink, Νicholas Barlow, Jamie S. Simpson, M.J. Scanlon, Bimbil Graham, Adam McCluskey, Phillip J. Robinson, Virginie Escriou, Romina Nassini, Serena Materazzi, Pierangelo Geppetti, Gareth A. Hicks, MacDonald J. Christie, Christopher J. H. Porter, Meritxell Canals, Nigel W. Bunnett - Science Translational Medicine 2017 被引用: 241

  8. 50 years of oral lipid-based formulations: Provenance, progress and future perspectives

    著者: Orlagh M. Feeney, Matthew Crum, Claire L. McEvoy, Natalie L. Trevaskis, Hywel D. Williams, Colin W. Pouton, William N. Charman, Christel A. S. Bergström, Christopher J. H. Porter - Advanced Drug Delivery Reviews 2016 被引用: 421

  9. Subcutaneous drug delivery and the role of the lymphatics

    著者: Danielle N McLennan, Christopher J. H. Porter, Susan A. Charman - Drug Discovery Today Technologies 2005 被引用: 260

  10. Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesity

    著者: Enyuan Cao, Matthew J. Watt, Cameron J. Nowell, Tim Quach, Jamie S. Simpson, Vilena De Melo Ferreira, Sonya Agarwal, Hannah X. Chu, Anubhav Srivastava, Dovile Anderson, Gracia Gracia, Alina D. Lam, Gabriela Segal, Jiwon Hong, Luojuan Hu, Kian Liun Phang, Alistair B.J. Escott, John A. Windsor, Anthony R. J. Phillips, Darren J. Creek, Natasha L. Harvey, Christopher J. H. Porter, Natalie L. Trevaskis - Nature Metabolism 2021 被引用: 103

  11. Beyond the Endosomal Bottleneck: Understanding the Efficiency of mRNA/LNP Delivery

    著者: Haiyin Liu, Moore Chen, Thomas J. Payne, Christopher J. H. Porter, Colin W. Pouton, Angus P. R. Johnston - Advanced Functional Materials 2024 被引用: 66

  12. Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome

    著者: Nestor N. Jiménez-Vargas, Luke A. Pattison, Peishen Zhao, TinaMarie Lieu, Rocco Latorre, Dane D. Jensen, Joel Castro, Luigi Aurelio, Giang T. Le, Bernard L. Flynn, Carmen Klein Herenbrink, Holly R. Yeatman, Laura E. Edgington‐Mitchell, Christopher J. H. Porter, Michelle L. Halls, Meritxell Canals, Nicholas A. Veldhuis, Daniel P. Poole, Peter McLean, Gareth A. Hicks, Nicole N. Scheff, Elyssa Chen, Aditi Bhattacharya, Brian L. Schmidt, Stuart M. Brierley, Stephen Vanner, Nigel W. Bunnett - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 被引用: 182

  13. Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update

    著者: Natalie L. Trevaskis, William N. Charman, Christopher J. H. Porter - Advanced Drug Delivery Reviews 2007 被引用: 435

  14. Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission

    著者: Rebecca Yarwood, Wendy L. Imlach, TinaMarie Lieu, Nicholas A. Veldhuis, Dane D. Jensen, Carmen Klein Herenbrink, Luigi Aurelio, Zhijian Cai, MacDonald J. Christie, Daniel P. Poole, Christopher J. H. Porter, Peter McLean, Gareth A. Hicks, Pierangelo Geppetti, Michelle L. Halls, Meritxell Canals, Nigel W. Bunnett - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 被引用: 183

  15. Enhancing intestinal drug solubilisation using lipid-based delivery systems

    著者: Christopher J. H. Porter, Colin W. Pouton, Jean F. Cuiné, William N. Charman - Advanced Drug Delivery Reviews 2007 被引用: 682

  16. Computational prediction of formulation strategies for beyond-rule-of-5 compounds

    著者: Christel A. S. Bergström, William N. Charman, Christopher J. H. Porter - Advanced Drug Delivery Reviews 2016 被引用: 196

  17. Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy

    著者: Lisa M. Kaminskas, Victoria M. McLeod, Gemma M. Ryan, Brian D. Kelly, John M. Haynes, Mark Williamson, Neeranat Thienthong, David J. Owen, Christopher J. H. Porter - Journal of Controlled Release 2014 被引用: 188

  18. Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network

    著者: Zahari Vinarov, Bertil Abrahamsson, Per Artursson, Hannah Batchelor, Philippe Berben, Andreas Bernkop‐Schnürch, James Butler, Jens Ceulemans, Nigel Davies, Didier Dupont, Gøril Eide Flaten, Nikoletta Fotaki, Brendan T. Griffin, Vincent Jannin, Janneke Keemink, Filippos Kesisoglou, Mirko Koziolek, Martin Kuentz, Alan R. Mackie, Antonio J. Meléndez‐Martínez, Mark McAllister, Anette Müllertz, Caitríona M. O’Driscoll, Neil Parrott, Jadwiga Paszkowska, Petr Pávek, Christopher J. H. Porter, Christos Reppas, Cordula Stillhart, Kiyohiko Sugano, Elena Toader, Kateřina Valentová, Maria Vertzoni, Saskia N. de Wildt, Clive Wilson, Patrick Augustijns - Advanced Drug Delivery Reviews 2021 被引用: 145

  19. Nano-chemotherapeutics: Maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers

    著者: Gemma M. Ryan, Lisa M. Kaminskas, Christopher J. H. Porter - Journal of Controlled Release 2014 被引用: 133

  20. Transformation of Poorly Water-Soluble Drugs into Lipophilic Ionic Liquids Enhances Oral Drug Exposure from Lipid Based Formulations

    著者: Yasemin Sahbaz, Hywel D. Williams, Tri‐Hung Nguyen, Jessica Saunders, Leigh Ford, Susan A. Charman, Peter J. Scammells, Christopher J. H. Porter - Molecular Pharmaceutics 2015 被引用: 161

  21. Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy

    著者: Eunice E. To, Ross Vlahos, Raymond Luong, Michelle L. Halls, Patrick C. Reading, Paul T. King, Christopher T. Chan, Grant R. Drummond, Christopher G. Sobey, Brad R. S. Broughton, Malcolm R. Starkey, Renée M. van der Sluis, Sharon R. Lewin, Steven Bozinovski, Luke O'neill, Tim Quach, Christopher J. H. Porter, Doug A. Brooks, John O’Leary, Stavros Selemidis - Nature Communications 2017 被引用: 153

  22. Fatty Acid-Binding Protein 5 Facilitates the Blood–Brain Barrier Transport of Docosahexaenoic Acid

    著者: Yijun Pan, M.J. Scanlon, Yuji Owada, Yui Yamamoto, Christopher J. H. Porter, Joseph A. Nicolazzo - Molecular Pharmaceutics 2015 被引用: 137

  23. Fatty Acid-Binding Protein 5 at the Blood–Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function

    著者: Yijun Pan, Jennifer L. Short, Kwok Ho Christopher Choy, Annie Xu Zeng, Philip J. Marriott, Yuji Owada, M.J. Scanlon, Christopher J. H. Porter, Joseph A. Nicolazzo - Journal of Neuroscience 2016 被引用: 98

  24. Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport

    著者: Aurelia S. Elz, Natalie L. Trevaskis, Christopher J. H. Porter, Joanne M. Bowen, Clive A. Prestidge - Journal of Controlled Release 2021 被引用: 47